Bright Peak Therapeutics
About:
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Website: https://brightpeaktx.com
Top Investors: BlackRock, RA Capital Management, Alexandria Venture Investments, Fidelity, Invus
Description:
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. The company's immunotherapies allow tissue and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy.
$232M
$1M to $10M
Basel, Basel-Stadt, Switzerland
2017-01-01
Jeffrey Bode, Vijaya Pattabiraman
51-100
2024-06-11
Private
© 2025 bioDAO.ai